MedPath

ENOSE in Pulmonary Tuberculosis in Yogyakarta

Not Applicable
Completed
Conditions
Pulmonary Tuberculosis Suspected
Pulmonary Tuberculosis TB (+) Histology, (-) Bacteriology
Other Specified Chronic Obstructive Pulmonary Disease
Registration Number
NCT02219945
Lead Sponsor
Tjip van der Werf
Brief Summary

Electronic noses detecting patterns of volatile molecules have recently been introduced for different diagnostic purposes. The diagnostic accuracy of a prototype e-nose device (Bruins et al (2013) in Bangladesh showed sensitivity of 76.5-95.9% and specificity of 85.3-98.5%. Here the investigators test a production type point-of-care hand-held device with less detectors. The investigators explore factors such as food intake, smoking, and co-morbidity, as well as the impact of TB treatment, and address the question whether the device could help monitor disease and response to treatment.

Detailed Description

Study participants provide WIC and after time for consideration, when they approve, provide demographic anonymized data.

The study population consists of six groups:

Group 1 - 20 TB patients aged \> 18 yrs Group 2 - 20 non---TB patients \> 18 yrs (screened for TB - other conditions) Group 3 - 20 patients with a lung disease - no TB suspects (Lung Clinics in Yogyakarta,Indonesia; Group 4 - 50 apparently healthy matched controls Group 5 - 20 newly diagnosed TB patients enrolled before start of treatment, to be followed over time, until after end of treatment (8 months FU).

Group 6 - 50 apparently healthy volunteers.

Study participants breath normally by mouthpiece into the device using a nose clamp - for 5 min during each sampling.

Electronic data are downloaded and transmitted by internet to Zutphen, Netherlands where data are processed to build the model.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
389
Inclusion Criteria
  • age >18yrs
  • voluntarily participating
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
diagnostic precision of electronic nose signal in pulmonary TB18 months

sensitivity and specificity of electronic nose signal in diagnosing and measuring response to treatment in pulmonary TB

Secondary Outcome Measures
NameTimeMethod
measuring response to TB treatment over time with the electronic nose18 months

cohort of patients newly deteted with PTB will be followed with the enose device over time to monitor disease activity, until end of treatment

Trial Locations

Locations (1)

patients - at 5 lung clinics (Minggiran, Kalasan, Kotagede, Bantul, Kuonprogo) connected with Sudjarto Teachnig Hospital; healthy controls among students and staff of Hospital and Gadjah Mada Universitas

🇮🇩

Yogyakarta, Jalan Kesehatan no.1, Yogyakarta, Indonesia

patients - at 5 lung clinics (Minggiran, Kalasan, Kotagede, Bantul, Kuonprogo) connected with Sudjarto Teachnig Hospital; healthy controls among students and staff of Hospital and Gadjah Mada Universitas
🇮🇩Yogyakarta, Jalan Kesehatan no.1, Yogyakarta, Indonesia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.